您的位置: 首页 > 农业专利 > 详情页

γ delta cells of modification and application thereof
专利权人:
TC BIOPHARM LTD
发明人:
LEEK, Michael David,HANNIGAN, Adele,PATAKAS, Agapitos,PARUZINA, Daria
申请号:
SG11201708401W
公开号:
SG11201708401WA
申请日:
2016.04.14
申请国别(地区):
SG
年份:
2017
代理人:
摘要:
The present invention provides the compositions and method for treating cancer or infectious diseases in the mankind. The present invention includes the generation and application of gamma delta T cells, the gamma delta T cells express Chimeric antigen receptor (CAR), and the Chimeric antigen receptor (CAR) includes antigen-binding domains, hinge domain, transmembrane domain, includes or the costimulatory signal conducting structure domain not comprising CD3 ζ signal transduction structural domains. It omits expression of the CAR sequences of CD3 ζ signal transduction structural domains in gamma delta T cells and provides internal CAR-T treatments, the target cell that gamma delta T cells receptor (TCR) will be only activated to ligand is provided generates cell dissolution.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充